UC San Diego will be one of several sites across the country to study the safety and efficacy of the drug tecovirimat as a potential treatment for human monkeypox, it was announced Thursday.
UC San Diego will be one of several sites across the country to study the safety and efficacy of the drug tecovirimat as a potential treatment for human monkeypox, it was announced Thursday.